Metharbital

From Wikipedia, the free encyclopedia

Metharbital
Systematic (IUPAC) name
5,5-diethyl-1-methyl-hexahydropyrimidine-2,4,6-trione
Identifiers
CAS number 50-11-3
ATC code N03AA30
PubChem 4099
DrugBank APRD00757
Chemical data
Formula C9H14N2O3 
Mol. mass 198.219 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Metharbital was patented in 1905 by Emil Fischer working for Merck[1]. It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy. It has similar properties to phenobarbital.

[edit] History

  • 1952 Gemonil was introduced by Abbott Laboratories.
  • 1990 Abbott stopped marketing.

[edit] References

  1. ^ US Patent 782742